Mitochondrial defects lie at the basis of neutropenia in Barth syndrome

Current Opinion in Hematology

Volumn 16, Issue 1, 2009, Pages 14-19

  Van Raam, Bram J ^a   Kuijpers, Taco W ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Barth syndrome; Cardiolipin; Mitochondria; Neutropenia; Neutrophils

Indexed keywords

CARDIOLIPIN; CELL NUCLEUS DNA; CYTOCHROME C OXIDASE; HYPOXIA INDUCIBLE FACTOR 1; LIPOCORTIN 5; MITOCHONDRIAL DNA; MITOCHONDRIAL PROTEIN; MONOLYSOCARDIOLIPIN; PHOSPHATIDYLSERINE; PROTEIN HAX1; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE); REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SECOND MITOCHONDRIAL ACTIVATOR OF CASPASE; SERINE PROTEINASE OMI; SUCCINATE DEHYDROGENASE (UBIQUINONE); UBIQUINOL CYTOCHROME C REDUCTASE; UNCLASSIFIED DRUG;

APOPTOSIS; BARTH SYNDROME; BONE MARROW BIOPSY; CELL FUNCTION; CELL SURVIVAL; CLINICAL FEATURE; DISEASE ASSOCIATION; DISORDERS OF MITOCHONDRIAL FUNCTIONS; GENE DELETION; GENE MUTATION; HUMAN; KOSTMANN SYNDROME; LYMPHOBLAST; MITOCHONDRIAL MEMBRANE POTENTIAL; MYELOID PROGENITOR CELL; NEUTROPENIA; NEUTROPHIL; NONHUMAN; PEARSON SYNDROME; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FUNCTION; RESPIRATORY CHAIN; REVIEW; SIGNAL TRANSDUCTION;

HUMANS; MITOCHONDRIA; MITOCHONDRIAL DISEASES; NEUTROPENIA; NEUTROPHILS; PHOSPHATIDYLSERINES; REACTIVE OXYGEN SPECIES; SYNDROME;

EID: 58149125206     PISSN: 10656251     EISSN: 15317048     Source Type: Journal    
DOI: 10.1097/MOH.0b013e32831c83f3     Document Type: Review

References (49)

1. Barth PG, Scholte HR, Berden JA, et al. An X-linked mitochondrial disease affecting cardiac muscle, skeletal muscle and neutrophil leucocytes. J Neurol Sci 1983; 62:327-355.
2. Kuijpers TW, Maianski NA, Tool AT, et al. Neutrophils in Barth syndrome (BTHS) avidly bind annexin-V in the absence of apoptosis. Blood 2004; 103:3915-3923. This is the first, and thus far the only, study to focus on the neutrophils in BTHS patients.
3. Barth PG, Valianpour F, Bowen VM, et al. X-linked cardioskeletal myopathy and neutropenia (Barth syndrome): an update. Am J Med Genet A 2004; 126:349-354.
4. Spencer CT, Bryant RM, Day J, et al. Cardiac and clinical phenotype in Barth syndrome. Pediatrics 2006; 118:e337-e346. This article provides a sound clinical description of the BTHS phenotype.
5. Bolhuis PA, Hensels GW, Hulsebos TJ, et al. Mapping of the locus for X-linked cardioskeletal myopathy with neutropenia and abnormal mitochondria (Barth syndrome) to Xq28. Am J Hum Genet 1991; 48:481-485.
6. Gedeon AK, Wilson MJ, Colley AC, et al. X linked fatal infantile cardiomyopathy maps to Xq28 and is possibly allelic to Barth syndrome. J Med Genet 1995; 32:383-388.
7. Bione S, D'Adamo P, Maestrini E, et al. A novel X-linked gene, G4. 5. is responsible for Barth syndrome. Nat Genet 1996; 12:385-389.
8. Neuwald AF. Barth syndrome may be due to an acyltransferase deficiency. Curr Biol 1997; 7:R465-R466.
9. Schlame M, Kelley RI, Feigenbaum A, et al. Phospholipid abnormalities in children with Barth syndrome. J Am Coll Cardiol 2003; 42:1994-1999.
10. Vreken P, Valianpour F, Nijtmans LG, et al. Defective remodeling of cardiolipin and phosphatidylglycerol in Barth syndrome. Biochem Biophys Res Commun 2000; 279:378-382.
11. Vaz FM, Houtkooper RH, Valianpour F, et al. Only one splice variant of the human TAZ gene encodes a functional protein with a role in cardiolipin metabolism. J Biol Chem 2003; 278:43089-43094. The above study describes the nature and function of tafazzin.
12. Roos D, van Bruggen R, Meischl C. Oxidative killing of microbes by neutrophils. Microbes Infect 2003; 5:1307-1315.
13. Pham CT. Neutrophil serine proteases: specific regulators of inflammation. Nat Rev Immunol 2006; 6:541-550.
14. van Raam BJ, Drewniak A, Groenwold V, et al. Granulocyte colony-stimulating factor delays neutrophil apoptosis by inhibition of calpains upstream of caspase-3. Blood 2008; 112:2046-2054.
15. Maianski NA, Mul FP, van Buul JD, et al. Granulocyte colony-stimulating factor inhibits the mitochondria-dependent activation of caspase-3 in neutrophils. Blood 2002; 99:672-679.
16. van den Berg JM, Weyer S, Weening JJ, et al. Divergent effects of tumor necrosis factor alpha on apoptosis of human neutrophils. J Leukoc Biol 2001; 69:467-473.
17. Klebanoff SJ, Clark RX. The neutrophil: function and clinical disorders. Amsterdam: North-Holland Publishing Co.; 1978.
18. Maianski NA, Geissler J, Srinivasula SM, et al. Functional characterization of mitochondria in neutrophils: a role restricted to apoptosis. Cell Death Differ 2004; 11:143-153.
19. Borregaard N, Herlin T. Energy metabolism of human neutrophils during phagocytosis. J Clin Invest 1982; 70:550-557.
20. Fossati G, Moulding DA, Spiller DG, et al. The mitochondrial network of human neutrophils: role in chemotaxis, phagocytosis, respiratory burst activation, and commitment to apoptosis. J Immunol 2003; 170:1964-1972.
21. van Raam BJ, Sluiter W, de Wit E, et al. Mitochondrial membrane potential in human neutrophils is maintained by complex III activity in the absence of supercomplex organisation. PLoS ONE 2008; 3:e2013. This article describes, in detail, the metabolic properties of neutrophil mitochondria, including their lack of respiratory super complexes.
22. Wittig I, Carrozzo R, Santorelli FM, Schagger H. Supercomplexes and subcomplexes of mitochondrial oxidative phosphorylation. Biochim Biophys Acta 2006; 1757:1066-1072. This article describes the respiratory string model for super-complex organization.
23. Brandner K, Mick DU, Frazier AE, et al. Taz1, an outer mitochondrial membrane protein, affects stability and assembly of inner membrane protein complexes: implications for Barth syndrome. Mol Biol Cell 2005; 16:5202-5214. This article highlights the involvement of Taz1 (tafazzin) in the super-complex organization of the respiratory chain.
24. Xu Y, Sutachan JJ, Plesken H, et al. Characterization of lymphoblast mitochondria from patients with Barth syndrome. Lab Invest 2005; 85:823-830. This article provides a detailed overview of the characteristics of BTHS mitochondria.
25. Acehan D, Xu Y, Stokes DL, Schlame M. Comparison of lymphoblast mitochondria from normal subjects and patients with Barth syndrome using electron microscopic tomography. Lab Invest 2007; 87:40-48. In this article, advanced visualization techniques are utilized to study the properties of BTHS mitochondria.
26. Kobayashi N, Karisola P, Pena-Cruz V, et al. TIM-1 and TIM-4 glycoproteins bind phosphatidylserine and mediate uptake of apoptotic cells. Immunity 2007; 27:927-940. This article describes two phosphatidyl serine receptors that may be involved in the clearance of BTHS neutrophils.
27. Park SY, Jung MY, Kim HJ, et al. Rapid cell corpse clearance by stabilin-2, a membrane phosphatidylserine receptor. Cell Death Differ 2008; 15:192-201. This article describes an alternative phosphatidyl serine receptor.
28. Appelt U, Sheriff A, Gaipl US, et al. Viable, apoptotic and necrotic monocytes expose phosphatidylserine: cooperative binding of the ligand annexin V to dying but not viable cells and implications for PS-dependent clearance. Cell Death Differ 2005; 12:194-196.
29. Pearson HA, Lobel JS, Kocoshis SA, et al. A new syndrome of refractory sideroblastic anemia with vacuolization of marrow precursors and exocrine pancreatic dysfunction. J Pediatr 1979; 95:976-984.
30. Carlsson G, Aprikyan AA, Tehranchi R, et al. Kostmann syndrome: severe congenital neutropenia associated with defective expression of Bcl-2, constitutive mitochondrial release of cytochrome c, and excessive apoptosis of myeloid progenitor cells. Blood 2004; 103:3355-3361.
31. Kostmann R. Infantile genetic agranulocytosis; agranulocytosis infantilis hereditaria. Acta Paediatr Suppl 1956; 45:1-78.
32. Thorburn DR, Dahl HH. Mitochondrial disorders: genetics, counseling, prenatal diagnosis and reproductive options. Am J Med Genet 2001; 106:102-114.
33. Suzuki Y, Demoliere C, Kitamura D, et al. HAX-1, a novel intracellular protein, localized on mitochondria, directly associates with HS1, a substrate of Src family tyrosine kinases. J Immunol 1997; 158:2736-2744.
34. Klein C, Grudzien M, Appaswamy G, et al. HAX1 deficiency causes autosomal recessive severe congenital neutropenia (Kostmann disease). Nat Genet 2007; 39:86-92. This article describes the cause of Kostmann disease.
35. Chao JR, Parganas E, Boyd K, et al. Hax1-mediated processing of HtrA2 by Parl allows survival of lymphocytes and neurons. Nature 2008; 452:98-102. This article describes the mechanism underlying Kostmann disease.
36. Kuwana T, Mackey MR, Perkins G, et al. Bid, Bax, and lipids cooperate to form supramolecular openings in the outer mitochondrial membrane. Cell 2002; 111:331-342.
37. Hegde R, Srinivasula SM, Zhang Z, et al. Identification of Omi/HtrA2 as a mitochondrial apoptotic serine protease that disrupts inhibitor of apoptosis protein-caspase interaction. J Biol Chem 2002; 277:432-438.
38. Blink E, Maianski NA, Alnemri ES, et al. Intramitochondrial serine protease activity of Omi/HtrA2 is required for caspase-independent cell death of human neutrophils. Cell Death Differ 2004; 11:937-939.
39. Morikawa Y, Matsuura N, Kakudo K, et al. Pearson's marrow/pancreas syndrome: a histological and genetic study. Virchows Arch A Pathol Anat Histopathol 1993; 423:227-231.
40. Knerr I, Metzler M, Niemeyer CM, et al. Hematologic features and clinical course of an infant with Pearson syndrome caused by a novel deletion of mitochondrial DNA. J Pediatr Hematol Oncol 2003; 25:948-951.
41. Muraki K, Nishimura S, Goto Y, et al. The association between haematological manifestation and mtDNA deletions in Pearson syndrome. J Inherit Metab Dis 1997; 20:697-703.
42. van Werkhoven MA, Thorburn DR, Gedeon AK, Pitt JJ. Monolysocardiolipin in cultured fibroblasts is a sensitive and specific marker for Barth syndrome. J Lipid Res 2006; 47:2346-2351. This article discusses monolysocardiolipin as a marker for BTHS.
43. Valianpour F, Mitsakos V, Schlemmer D, et al. Monolysocardiolipins accumulate in Barth syndrome but do not lead to enhanced apoptosis. J Lipid Res 2005; 46:1182-1195. This article excludes apoptosis as a cause for BTHS.
44. Walmsley SR, Print C, Farahi N, et al. Hypoxia-induced neutrophil survival is mediated by HIF-1alpha-dependent NF-kappaB activity. J Exp Med 2005; 201:105-115.
45. Metzen E, Ratcliffe PJ. HIF hydroxylation and cellular oxygen sensing. Biol Chem 2004; 385:223-230.
46. Chandel NS, McClintock DS, Feliciano CE, et al. Reactive oxygen species generated at mitochondrial complex III stabilize hypoxia-inducible factor-1alpha during hypoxia: a mechanism of O2 sensing. J Biol Chem 2000; 275:25130-25138.
47. Takekoshi S, Kambayashi Y, Nagata H, et al. Activation of protein kinase C by oxidized diacylglycerols. Biochem Biophys Res Commun 1995; 217:654-660.
48. de Jong K, Rettig MP, Low PS, Kuypers FA. Protein kinase C activation induces phosphatidylserine exposure on red blood cells. Biochemistry 2002; 41:12562-12567.
49. Frasch SC, Henson PM, Kailey JM, et al. Regulation of phospholipid scramblase activity during apoptosis and cell activation by protein kinase Cdelta. J Biol Chem 2000; 275:23065-23073.